מהו מהסתיידות?

Recent Arteriosclerosis News

• Alnylam first quarter revenues decrease to $20.6 millionAlnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter 2012, and company highlights.
• Perivascular fat tissue may influence onset of atherosclerosisResearchers at UC have confirmed that fat surrounding the outside of arteries in humans-particularly the left coronary artery-may influence the onset of coronary artery disease, or atherosclerosis, wh...
• Positive results from Alnylam’s ALN-PCS Phase I trial on severe hypercholesterolemiaAlnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today positive results from its Phase I clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment o...
• Depression may increase risk of peripheral artery diseaseDepression may be associated with an increased risk of arterial narrowing in the legs and pelvis, a condition known as peripheral artery disease (PAD), according to research presented at the American ...
• HDAC9 gene can lead to obesity-induced body fat dysfunctionCardiac researchers at the University of Cincinnati (UC) have found that a certain cellular pathway is linked to obesity-related disorders, like diabetes, heart disease and fatty liver disease.